托烷司琼与昂丹司琼预防全身麻醉术后恶心呕吐效果的比较:系统评价和Meta分析

doi:10.3969/j.issn.1006-7795.2016.03.028

摘要/Abstract

摘要： 目的系统评价托烷司琼与昂丹司琼预防全身麻醉(以下简称全麻)术后恶心呕吐的效果。方法遵循PRISMA声明,系统检索了PubMed、EMBASE、Cochrane Central Register of Controlled Trials、Web of Science、CNKI、CBM、万方和维普数据库中有关静脉注射托烷司琼与昂丹司琼后24 h内预防全麻术后恶心呕吐的随机对照临床试验。检索时限为从建库至2015年9月。研究者筛选文献,对纳入的研究进行质量评价、数据提取和Meta分析,并对证据进行GRADE分级。结果共纳入9篇临床试验报道。Meta分析结果显示,与安慰剂相比,托烷司琼和昂丹司琼均能有效地预防术后恶心呕吐 [RR=0.62, 95%CI(0.43,0.90),P=0.01] [RR=0.67, 95% CI(0.49,0.90), P=0.009];托烷司琼与昂丹司琼预防术后恶心呕吐、术后呕吐、术后恶心的效果差异无统计学意义 [RR=0.95, 95%CI(0.81,1.11), P=0.50] [RR=1.26, 95%CI(0.83,1.91), P=0.28] [RR=0.88, 95%CI(0.42,1.83), P=0.73]。结论在术后24 h内托烷司琼与昂丹司琼均能有效地预防术后恶心呕吐,但就目前的证据而言,托烷司琼与昂丹司琼预防术后恶心呕吐的效果没有差别。

关键词: 托烷司琼, 昂丹司琼, 术后恶心呕吐, Meta分析, 随机对照试验

Abstract: Objective To systematically review the effects of tropisetron and ondansetron on preventing postoperative nausea and vomiting (PONV). Methods According to the PRISMA statement, PubMed, EMBASE, Cochrane Central Register of Controlled Trials, Web of Science, CNKI, CBM, WanFang Data and VIP databases were searched for random controlled trials involving tropisetron and ondansetron on preventing postoperative nausea and vomiting within first 24 hours after surgery from the date of establishment of databases to September, 2015. Researchers screened the studies, evaluated the quality of included studies, extracted data, conducted Meta-analysis and classified the evidence using GRADE system. Results Totally 9 trials were included. Meta-analysis showed that compared with placebo, both tropisetron and ondansetron could effectively prevent PONV [RR=0.62, 95% CI(0.43,0.90), P=0.01]RR=0.67, 95%CI(0.49,0.90), P=0.009]. There were no significant difference between tropisetron and ondansetron on preventing PONV, POV, PON [RR=0.95, 95% CI(0.81,1.11), P=0.50] [RR=1.26, 95% CI(0.83,1.91), P=0.28] [RR=0.88, 95% CI(0.42,1.83), P=0.73]. Conclusion Tropisetron and ondansetron could provide equal effective prophylaxis of PONV within 24 hours after surgery. But according to the currently available evidence, there were no significant difference between tropisetron and ondansetron on preventing PONV.

Key words: tropisetron, ondansetron, postoperative nausea and vomiting, Meta-analysis, randomized controlled trial

中图分类号:

R969.4

聂洋洋, 史志国, 陈玢, 闫涛, 郑晖. 托烷司琼与昂丹司琼预防全身麻醉术后恶心呕吐效果的比较:系统评价和Meta分析[J]. 首都医科大学学报, 2016, 37(3): 391-399.

Nie Yangyang, Shi Zhiguo, Chen Bin, Yan Tao, Zheng Hui. Comparison of effects of tropisetron and ondansetron on preventing postoperative nausea and vomiting: a system review and Meta-analysis[J]. Journal of Capital Medical University, 2016, 37(3): 391-399.

参考文献

[1] Apfel C C, Läärä E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers [J]. Anesthesiology, 1999, 91(3): 693-700.
[2] Kazemi K F, Henzi I, Tramer M R. Treatment of established postoperative nausea and vomiting: a quantitative systematic review [J]. BMC anesthesiology, 2001, 1(1): 2.
[3] 吴新民, 罗爱伦, 田玉科,等. 术后恶心呕吐防治专家意见(2012) [J]. 临床麻醉学杂志, 2012, 28(4): 413-416.
[4] Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement [J]. Int J Surg, 2010, 8(5): 336-341.
[5] Higgins J, Altman D, Sterne J, et al. Chapter 8: Assessing risk of bias in included studies [M]//Higgins J P T, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. NewYork: Wiley, 2011.
[6] Atkins D, Best D, Briss P A, et al. Grading quality of evidence and strength of recommendations [J]. Bmj, 2004, 328(7454): 1490.
[7] Naguib M, el Bakry A K, Khoshim M H, et al. Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo [J]. Can J Anaesth, 1996, 43(3): 226-231.
[8] Scholz J, Hennes H J, Steinfath M, et al. Tropisetron or ondansetron compared with placebo for prevention of postoperative nausea and vomiting [J]. Eur J Anaesthesiol, 1998, 15(6): 676-685.
[9] 徐康清, 王彪, 黄文起,等. 不同剂量5-HT_3受体拮抗剂托烷司琼对全麻术后恶心呕吐的影响的临床研究 [J]. 国外医学麻醉学与复苏分册, 2005, 26(1): 1-3.
[10] 李红玲, 彭昆, 韩如泉,等. 托烷司琼用于预防神经外科术后恶心呕吐的研究 [J]. 天津医药, 2006, 34(8): 550-552.
[11] 赵东, 潘芳, 杨拔贤. 术后恶心呕吐发生率与预防性用药的意义 [J]. 临床麻醉学杂志, 2006, 22(12): 912-914.
[12] Quan X, Ye T H, Zhu B. A randomized double-blind study of prevention of postoperative nausea and vomiting with ondansetron, tropisetron, or granisetron in patients undergoing general anesthesia [J]. Zhongguo yi xue ke xue yuan xue bao, 2007, 29(1): 107-110.
[13] 龚清安, 李莹, 司小萌. 托烷司琼预防腹腔镜胆囊切除术后恶心呕吐的观察 [J]. 中国医师进修杂志(综合版), 2007, 30(4): 55-56.
[14] Ekinci O, Malat I, Isitmangil G, et al. A randomized comparison of droperidol, metoclopramide, tropisetron, and ondansetron for the prevention of postoperative nausea and vomiting [J]. Gynecol Obstet Invest, 2011, 71(1): 59-65.
[15] Metaxari M, Papaioannou A, Petrou A, et al. Antiemetic prophylaxis in thyroid surgery: a randomized, double-blind comparison of three 5-HT3 agents [J]. J Anesth, 2011, 25(3): 356-362.
[16] Smith C A, Ruth-Sahd L. Reducing the incidence of postoperative nausea and vomiting begins with risk screening: an evaluation of the evidence [J]. J Perianesth Nurs, 2016, 31(2): 158-171.
[17] Craig J, Powell B. The management of nausea and vomiting in clinical oncology [J]. Am J Med Sci, 1987, 293(1): 34-44.
[18] Veyrat-Follet C, Farinotti R, Palmer J L. Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds [J]. Drugs, 1997, 53(2): 206-234.
[19] Gregory R E, Ettinger D S. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy [J]. Drugs, 1998, 55(2): 173-189.
[20] Prathep S, Mahattanaporn S, Wasinwong W. Target controlled infusion versus sevoflurane/desflurane anesthesia for laparoscopic cholecystectomy: comparison postoperative nausea/vomiting and extubation time [J]. J Med Assoc Thai, 2015, 98(12): 1187-1192.
[21] Lim H, Doo A R, Son J S, et al. Effects of intraoperative single bolus fentanyl administration and remifentanil infusion on postoperative nausea and vomiting [J]. Korean J Anesthesiol, 2016, 69(1): 51-56.
[22] 屈淑贤, 郑振东,刘兆喆,等. 帕洛诺司琼防治乳腺癌化疗相关性恶心呕吐的临床对照研究[J]. 解放军医药杂志,2014,26(3):27-30.
[23] 董良, 李海金,赵建刚,等. 帕洛诺司琼预防成人化疗所致恶心呕吐随机对照试验Meta分析[J]. 中华肿瘤防治杂志,2014,21(18):1461-1467.
[24] Bataille A, Letourneulx J F, Charmeau A, et al. Impact of prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind placebo study [J]. Eur J Anaesthesiol, 2016, Feb 10, [EPub ahead of Print].